Lonza recorded net profits of 237.0 million Swiss francs ($274.9 million) for 2014 compared with profits of SF87.0 million in 2013. Sales for 2014 increased by 1.6%, to SF3.64 billion. Lonza’s specialty ingredients and pharma and biotech market segments both performed solidly despite currency headwinds and the performance of the water treatment business, and most of the individual businesses performed according to expectations, Lonza says.
展开▼
